Evidence map›Paper›PMID 40279421›Full record

ArticleScience advances2025

Prolonged airway explant culture enables study of health, disease, and viral pathogenesis.

Rhianna E Lee-Ferris, Kenichi Okuda, Jacob R Galiger, Stephen A Schworer, Troy D Rogers, Hong Dang, Rodney Gilmore, Caitlin Edwards, Gillian Crisp, Satoko Nakano and 11 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Optimized AAV capsids robustly transduce airway epithelial cells.bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Rhianna E Lee-FerrisMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-2039-1304
Kenichi OkudaMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0001-9341-2730
Jacob R GaligerMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Stephen A SchworerMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0001-7741-8972
Troy D RogersMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0009-0003-5509-5051
Hong DangMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-7305-4208
Rodney GilmoreMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-3821-8422
Caitlin EdwardsEpidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-4228-2192
Gillian CrispMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Satoko NakanoMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Anne M CawleyMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Raymond J PicklesMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0001-8875-148X
Samuel C GallantMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-1841-3332
Elisa CrisciCollege of Veterinary Medicine, Department of Population Health and Pathobiology, North Carolina State University, Raleigh, NC, USA.ORCID 0000-0002-4235-8508
Lauraine RivierMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-0221-2440
James S HagoodMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-3938-0330
Wanda K O'NealMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0003-2412-5943
Ralph S BaricEpidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0001-6827-8701
Barbara R GrubbMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0009-0005-8036-2937
Richard C BoucherMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0002-5745-3989
Scott H RandellMarsico Lung Institute/CF Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID 0000-0001-5351-2841

Funding

Vector CoreP30DK065988 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Scott H Randell · 2004 to 2026
$26.5M
Stanford/UNC Biomimetic U19 Research CenterU19AI116484 · NIAID · STANFORD UNIVERSITY · PI GREENBERG, HARRY BERNARD · 2015 to 2025
$13.5M
Mechanisms of MERS-CoV Entry, Cross-species Transmission and PathogenesisR01AI110700 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BARIC, RALPH S, LI, FANG · 2015 to 2024
$7.4M
CTSA K12 Program at UNCK12TR004416 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michelle Hernandez, Jonathan J Juliano · 2023 to 2026
$6.5M
Mucociliary innate defense mechanism in the human distal airwayR01HL163602 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kenichi Okuda · 2023 to 2026
$2.4M
Training Program in Cellular Systems and Integrative PhysiologyT32GM133364 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Kathleen M Caron, Natasha T Snider · 2020 to 2026
$1.4M
Genetically Engineered Hamsters as Small Animal Models for Testing RSV TherapeuticsR21AI138247 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PICKLES, RAYMOND J · 2018 to 2019
$425k
Engineering Human Bronchial Epithelial Cells for Cystic Fibrosis Cell TherapyF31HL158197 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEE, RHIANNA E · 2021 to 2022
$67k
NCATS NIH HHS K12 TR004416NHLBI NIH HHS F31 HL158197NHLBI NIH HHS R01 HL163602NIAID NIH HHS R01 AI110700NIAID NIH HHS R21 AI138247NIAID NIH HHS U19 AI116484NIDDK NIH HHS P30 DK065988NIGMS NIH HHS T32 GM133364
6 · The paper itself

Abstract

In vitro models play a major role in studying airway physiology and disease. However, the native lung's complex tissue architecture and nonepithelial cell lineages are not preserved in these models. Ex vivo tissue models could overcome in vitro limitations, but methods for long-term maintenance of ex vivo tissue have not been established. Here, we describe methods to culture human large airway explants, small airway explants, and precision-cut lung slices for at least 14 days. Human airway explants recapitulate genotype-specific electrophysiology; characteristic epithelial, endothelial, stromal, and immune cell populations; and model viral infection after 14 days in culture. These methods also maintain mouse, rabbit, and pig tracheal explants. Notably, intact airway tissue can be cryopreserved, thawed, and used to generate viable explants with recovery of function 14 days postthaw. These studies highlight the broad applications of airway tissue explants and their use as translational intermediates between in vitro and in vivo studies.

Indexed as

LungTissue Culture TechniquesTracheaAnimalsCryopreservationHumansMiceRabbitsSwine

Identifiers

PMID40279421
PMCPMC12024639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.